Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients

QR Code

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients

Andrew J Yee, Noopur S RajeDivision of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USAAbstract: Bone loss is a common side effect of cancer treatments, especially antihormonal treatments used in the treatment of breast and prostate cancer. Denosumab is a monoclonal...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yee AJ, Raje NS
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2012
Sujets:	denosumab breast cancer prostate cancer bone loss Geriatrics RC952-954.6
Accès en ligne:	https://doaj.org/article/e634a06fd60f46699b3fc6394d02c27f
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Management of bone metastases in refractory prostate cancer – role of denosumab
par: Paller CJ, et autres
Publié: (2012)

Osteoporosis in men: epidemiology and treatment with denosumab
par: Sidlauskas KM, et autres
Publié: (2014)

High bone turnover status as a risk factor in symptomatic hypocalcemia following denosumab treatment in a male patient with osteoporosis
par: Ishikawa K, et autres
Publié: (2018)

Clinical utility of denosumab for treatment of bone loss in men and women
par: Adler R, et autres
Publié: (2011)

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
par: Anne-Priscille Trouvin, et autres
Publié: (2010)

Alveolar Bone Loss, Tooth Loss and Oral Cancer Mortality in Older Patients: A Retrospective Cohort Study
par: Qian Y, et autres
Publié: (2020)

Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer
par: Stefano Gonnelli, et autres
Publié: (2008)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
par: Sumanta Kumar Pal, et autres
Publié: (2010)

Dramatic response of aneurysmal bone cyst to denosumab: Case report and literature review
par: Pedram Fadavi, et autres
Publié: (2021)

Lactobacillus helveticus (ATCC 27558) upregulates Runx2 and Bmp2 and modulates bone mineral density in ovariectomy-induced bone loss rats
par: Parvaneh M, et autres
Publié: (2018)

Is there an optimal management for localized prostate cancer?
par: Jaspreet Singh, et autres
Publié: (2010)

Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte Ratio
par: Alberto Bongiovanni, et autres
Publié: (2021)

Emerging treatments for postmenopausal osteoporosis – focus on denosumab
par: Piet Geusens
Publié: (2009)

Analysis of three-dimensional bone mineral density and bone strength measured by quantitative computed tomography following denosumab discontinuation in a patient with postmenopausal osteoporosis
par: Tsuchiya K, et autres
Publié: (2019)

Treatment of primary osteoporosis in men
par: Giusti A, et autres
Publié: (2014)

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
par: Caffo O, et autres
Publié: (2016)

Six-month depot formulation of leuprorelin acetate in the treatment of prostate cancer
par: Rajni Sethi, et autres
Publié: (2009)

Prospective investigation of change in the prostate-specific antigens after various urologic procedures
par: Park SC, et autres
Publié: (2015)

The cognitive and psychosocial effects of auditory training and hearing aids in adults with hearing loss
par: Nkyekyer J, et autres
Publié: (2019)

Optimal breast cancer screening strategies for older women: current perspectives
par: Braithwaite D, et autres
Publié: (2016)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
par: Victor G Vogel
Publié: (2008)

Optimal management of breast cancer in the elderly patient: current perspectives
par: Le Saux O, et autres
Publié: (2015)

Hypercalcemia following discontinuation of denosumab therapy: A systematic review
par: Keisuke Horiuchi, et autres
Publié: (2021)

Diagnostic and therapeutic path of breast cancer: effectiveness, appropriateness, and costs – results from the DOCMa study
par: Giovagnoli MR, et autres
Publié: (2015)

Correlations between bone turnover markers, serum magnesium and bone mass density in postmenopausal osteoporosis
par: Mederle OA, et autres
Publié: (2018)

Degarelix and its therapeutic potential in the treatment of prostate cancer
par: Christian Doehn, et autres
Publié: (2009)

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
par: Tunn UW, et autres
Publié: (2013)

A decrease in NAD+ contributes to the loss of osteoprogenitors and bone mass with aging
par: Ha-Neui Kim, et autres
Publié: (2021)

Impact of Hearing Loss on Geriatric Assessment
par: Völter C, et autres
Publié: (2020)

In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
par: Chen L, et autres
Publié: (2018)

Serum total prostate-specific antigen values in men with symptomatic prostate enlargement in Nigeria: role in clinical decision-making
par: Nnabugwu II, et autres
Publié: (2014)

Prostatectomy using different lasers for the treatment of benign prostate hyperplasia in aging males
par: Lee WC, et autres
Publié: (2013)

Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer
par: Yuan J, et autres
Publié: (2019)

Factors associated with decreased bone mineral density in postmenopausal women with schizophrenia
par: Liang Y, et autres
Publié: (2016)

Effects of age, sex, and ethnicity on bone health status of the elderly in Kuala Lumpur, Malaysia
par: Chin KY, et autres
Publié: (2016)

The impact of hearing loss on language performance in older adults with different stages of cognitive function
par: Lodeiro-Fernández L, et autres
Publié: (2015)

The impact of hearing loss on the quality of life of elderly adults
par: Ciorba A, et autres
Publié: (2012)

Is it the resistance training itself or the combined associated weight loss that improves the metabolic syndrome-related phenotypes in postmenopausal women?
par: Soyluk O, et autres
Publié: (2015)

Cardiovascular and Other Competing Causes of Death in Male Breast Cancer Patients: A Population-Based Epidemiologic Study
par: Zhang H, et autres
Publié: (2021)

Alveolar Bone Loss with Microarchitecture Changes in Aged Rat
par: Zheng,Yong, et autres
Publié: (2021)